Managing diabetes requires accurate risk assessment to ensure patients get the right care at the right time. A new pilot study tested how well five different public AI web interfaces could handle these assessments. The researchers gave the AI 20 cases of diabetes data to see if the technology could match the decisions made by a team of medical experts.
The results were striking. The AI models achieved 100% agreement with the expert consensus on risk categories. They also performed well in identifying the need for referrals, the urgency of those referrals, and the specific type of specialist needed. In fact, the AI correctly identified the need for a referral in 89 out of 100 instances and correctly identified the urgency in 92 out of 100 cases.
While these results are promising, there are important limits to keep in mind. This was a small study of only 20 cases, and the researchers noted that a lack of safety errors in this small test does not mean the AI is safe for everyday use without a doctor. The study highlights that while AI can be a powerful tool for supporting decisions, it must be supervised by a clinician rather than used on its own.